vs
OFG BANCORP（OFG）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是OFG BANCORP的1.2倍（$219.9M vs $184.3M），OFG BANCORP净利率更高（30.3% vs -1.0%，领先31.3%），Orthofix Medical Inc.同比增速更快（2.0% vs 0.9%），OFG BANCORP自由现金流更多（$199.3M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 2.8%）
OFG Bancorp成立于1964年，总部位于波多黎各圣胡安，是东方银行的金融控股公司。公司通过东方银行、东方金融服务有限责任公司、东方保险有限责任公司等核心子公司，主要面向波多黎各和美属维尔京群岛市场，提供多元化的零售与商业银行、贷款、财富管理相关产品、服务及技术解决方案。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
OFG vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.2倍
$184.3M
营收增速更快
OFIX
高出1.1%
0.9%
净利率更高
OFG
高出31.3%
-1.0%
自由现金流更多
OFG
多$182.5M
$16.8M
两年增速更快
OFIX
近两年复合增速
2.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $184.3M | $219.9M |
| 净利润 | $55.9M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 25.7% | 0.2% |
| 净利率 | 30.3% | -1.0% |
| 营收同比 | 0.9% | 2.0% |
| 净利润同比 | 11.0% | 92.4% |
| 每股收益（稀释后） | $1.27 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFGOFIX
| Q4 25 | $184.3M | $219.9M | ||
| Q3 25 | $186.2M | $205.6M | ||
| Q2 25 | $182.4M | $203.1M | ||
| Q1 25 | $178.6M | $193.6M | ||
| Q4 24 | $182.7M | $215.7M | ||
| Q3 24 | $174.7M | $196.6M | ||
| Q2 24 | $179.8M | $198.6M | ||
| Q1 24 | $174.4M | $188.6M |
净利润OFGOFIX
| Q4 25 | $55.9M | $-2.2M | ||
| Q3 25 | $51.8M | $-22.8M | ||
| Q2 25 | $51.8M | $-14.1M | ||
| Q1 25 | $45.6M | $-53.1M | ||
| Q4 24 | $50.3M | $-29.1M | ||
| Q3 24 | $47.0M | $-27.4M | ||
| Q2 24 | $51.1M | $-33.4M | ||
| Q1 24 | $49.7M | $-36.0M |
毛利率OFGOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率OFGOFIX
| Q4 25 | 25.7% | 0.2% | ||
| Q3 25 | 33.0% | -8.3% | ||
| Q2 25 | 36.1% | -7.9% | ||
| Q1 25 | 33.3% | -25.2% | ||
| Q4 24 | 28.9% | -5.3% | ||
| Q3 24 | 35.4% | -9.6% | ||
| Q2 24 | 39.6% | -12.5% | ||
| Q1 24 | 38.9% | -15.6% |
净利率OFGOFIX
| Q4 25 | 30.3% | -1.0% | ||
| Q3 25 | 27.8% | -11.1% | ||
| Q2 25 | 28.4% | -6.9% | ||
| Q1 25 | 25.5% | -27.4% | ||
| Q4 24 | 27.6% | -13.5% | ||
| Q3 24 | 26.9% | -13.9% | ||
| Q2 24 | 28.4% | -16.8% | ||
| Q1 24 | 28.5% | -19.1% |
每股收益（稀释后）OFGOFIX
| Q4 25 | $1.27 | $-0.05 | ||
| Q3 25 | $1.16 | $-0.57 | ||
| Q2 25 | $1.15 | $-0.36 | ||
| Q1 25 | $1.00 | $-1.35 | ||
| Q4 24 | $1.10 | $-0.76 | ||
| Q3 24 | $1.00 | $-0.71 | ||
| Q2 24 | $1.08 | $-0.88 | ||
| Q1 24 | $1.05 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.4B | $450.0M |
| 总资产 | $12.5B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFGOFIX
| Q4 25 | $1.0B | $82.0M | ||
| Q3 25 | $740.3M | $62.9M | ||
| Q2 25 | $851.8M | $65.6M | ||
| Q1 25 | $710.6M | $58.0M | ||
| Q4 24 | $591.1M | $83.2M | ||
| Q3 24 | $680.6M | $30.1M | ||
| Q2 24 | $740.4M | $26.4M | ||
| Q1 24 | $754.4M | $27.0M |
总债务OFGOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益OFGOFIX
| Q4 25 | $1.4B | $450.0M | ||
| Q3 25 | $1.4B | $442.5M | ||
| Q2 25 | $1.3B | $458.3M | ||
| Q1 25 | $1.3B | $458.3M | ||
| Q4 24 | $1.3B | $503.1M | ||
| Q3 24 | $1.3B | $525.9M | ||
| Q2 24 | $1.2B | $546.0M | ||
| Q1 24 | $1.2B | $570.3M |
总资产OFGOFIX
| Q4 25 | $12.5B | $850.6M | ||
| Q3 25 | $12.2B | $832.6M | ||
| Q2 25 | $12.2B | $837.2M | ||
| Q1 25 | $11.7B | $823.1M | ||
| Q4 24 | $11.5B | $893.3M | ||
| Q3 24 | $11.5B | $867.9M | ||
| Q2 24 | $11.3B | $882.0M | ||
| Q1 24 | $11.2B | $906.0M |
负债/权益比OFGOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $217.7M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $199.3M | $16.8M |
| 自由现金流率自由现金流/营收 | 108.1% | 7.6% |
| 资本支出强度资本支出/营收 | 10.0% | 4.9% |
| 现金转化率经营现金流/净利润 | 3.90× | — |
| 过去12个月自由现金流最近4个季度 | $345.4M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流OFGOFIX
| Q4 25 | $217.7M | $27.7M | ||
| Q3 25 | $39.5M | $12.4M | ||
| Q2 25 | $35.9M | $11.6M | ||
| Q1 25 | $83.1M | $-18.4M | ||
| Q4 24 | $252.5M | $23.7M | ||
| Q3 24 | $58.1M | $11.7M | ||
| Q2 24 | $95.1M | $9.0M | ||
| Q1 24 | $61.0M | $-18.6M |
自由现金流OFGOFIX
| Q4 25 | $199.3M | $16.8M | ||
| Q3 25 | $35.5M | $2.5M | ||
| Q2 25 | $31.8M | $4.5M | ||
| Q1 25 | $78.7M | $-25.1M | ||
| Q4 24 | $231.2M | $15.2M | ||
| Q3 24 | $51.8M | $6.3M | ||
| Q2 24 | $90.4M | $-360.0K | ||
| Q1 24 | $54.8M | $-29.1M |
自由现金流率OFGOFIX
| Q4 25 | 108.1% | 7.6% | ||
| Q3 25 | 19.1% | 1.2% | ||
| Q2 25 | 17.4% | 2.2% | ||
| Q1 25 | 44.1% | -13.0% | ||
| Q4 24 | 126.5% | 7.0% | ||
| Q3 24 | 29.6% | 3.2% | ||
| Q2 24 | 50.3% | -0.2% | ||
| Q1 24 | 31.4% | -15.4% |
资本支出强度OFGOFIX
| Q4 25 | 10.0% | 4.9% | ||
| Q3 25 | 2.1% | 4.8% | ||
| Q2 25 | 2.3% | 3.5% | ||
| Q1 25 | 2.4% | 3.5% | ||
| Q4 24 | 11.7% | 4.0% | ||
| Q3 24 | 3.6% | 2.7% | ||
| Q2 24 | 2.6% | 4.7% | ||
| Q1 24 | 3.5% | 5.6% |
现金转化率OFGOFIX
| Q4 25 | 3.90× | — | ||
| Q3 25 | 0.76× | — | ||
| Q2 25 | 0.69× | — | ||
| Q1 25 | 1.82× | — | ||
| Q4 24 | 5.02× | — | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.86× | — | ||
| Q1 24 | 1.23× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFG
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
